Weili Dai

Director of Astrana Health

As of Nov 10, 2026: Weili Dai (Director, ASTH) reported no shares bought or sold themselves in the last 12 months (Form 4). ASTH's Quality Score is 5. Scores as of 10:56 PM ET, 15 minutes behind.

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Jun 10: stock award (4,525 ASTH shares).

Bought$012 months Sold$012 months Last filedJun 10stock award

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Weili Dai reported

None in the last 12 months, as filed.

Every Form 4 Weili Dai filed, as filed, on EDGAR

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See ASTH's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Weili Dai's companies

Where Weili Dai files, with the stock's Quality Score

Stock	Title, as filed	Trades	Quality Score
ASTHAstrana HealthDirector	Directortitle as of Jun 12	0	5

Alerts for Weili Dai

An email for each Form 4 Weili Dai files, with the stock's Quality Score.

Set an alert

A free account. No card.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Jun 10, 2026.

Their filings on the SEC's site

Free to reuse with a link to this page.

How to cite

Breakaway, Weili Dai: Director at Astrana Health (ASTH), insider trades, Jun 10, 2026, getbreakaway.com/insiders/weili-dai

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Astrana Health

Insider trades by person

Weili Dai

Every trade Weili Dai reported

Weili Dai's companies

Use this page

Others who file at Astrana Health

Every insider trade, with its stock's score.